Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor

Summary

Invariant Natural killer T (iNKT) cells are a unique subset of lymphocytes that express homogeneous TCR recognizing KRN7000 which was up-regulated by many kinds of cancer cells.The hypothesis of the investigators is that immunotherapy strategy of infusion of iNKT cells may resist inflection and decrease the tumor burden and improve overall survival. The purpose of this study is to assess the safety and efficacy of treatment of tuberculosis with malignant solid tumor by infusing of iNKT cells.

Timeline

Start

2018-01-01

Primary completion

2021-12-30

Completion

2022-03-31

Drugs

Indications